Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)	SCLC, Limited Stage	Recruiting	Phase 2	2025-04-04		NCT06911606

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangdong Provincial People's Hospital	164
Guangzhou No.12 People's Hospital	4
Liaoning Cancer Hospital & Institute	53
Second Xiangya Hospital of Central South University	95

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangdong Provincial People's Hospital	Guangzhou	China	59

Clinical trials